0001959173-24-003688.txt : 20240517 0001959173-24-003688.hdr.sgml : 20240517 20240517162258 ACCESSION NUMBER: 0001959173-24-003688 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240517 DATE AS OF CHANGE: 20240517 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-24006 FILM NUMBER: 24960104 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 4154825300 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC DATE OF NAME CHANGE: 19980723 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Wilson Mark Andrew CENTRAL INDEX KEY: 0001808356 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 1613 RAY DRIVE CITY: BURLINGAME STATE: CA ZIP: 94010 144 1 primary_doc.xml 144 0001808356 XXXXXXXX LIVE 0000906709 NEKTAR THERAPEUTICS 000-24006 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300 Wilson Mark Andrew Officer Common Fidelity Brokerage Services LLC

900 Salem Street Smithfield RI 02917

6260 10980.04 183624620 05/17/2024 NASDAQ Common 05/15/2024 Restricted Stock Vesting Issuer N 6260 05/15/2024 Compensation N Mark Wilson

455 Mission Bay Boulevard South San Francisco CA 94158

Common 02/20/2024 7606 5149.27 Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution. 05/17/2024 /S/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Mark Wilson